Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas

ArticleinApmis 111(11):1011-8 · December 2003with2 Reads
DOI: 10.1111/j.1600-0463.2003.apm1111103.x · Source: PubMed
Abstract
Angiogenesis is a key process in tumour growth and metastasis, and Factor-VIII microvascular density has been found to influence prognosis among endometrial carcinoma patients. The CD105/endoglin antibody has been reported to preferentially bind to activated endothelial cells in tissues participating in angiogenesis, and we therefore wanted to compare the prognostic significance of CD105/endoglin to that of Factor-VIII. In a population-based endometrial carcinoma study with long (median 11.5 years) and complete patient follow-up, mean intratumour microvascular density (MVD) assessed using CD105/endoglin was investigated and compared with previous data for MVD assessed using Factor-VIII. MVD by CD105/endoglin was significantly correlated with MVD by Factor-VIII (p=0.001). However, tumours within the two groups defined by the upper and lower quartiles for CD105/endoglin-MVD were both significantly more often metastatic (FIGO-stage III/IV; p=0.03), with high tumour cell proliferation by Ki67 (p=0.007) and with reduced survival (p=0.036) as compared with the intermediate groups. In Cox regression analysis, CD105/endoglin-MVD showed independent prognostic influence when analysed together with patient age, FIGO stage, histologic subtype, histologic grade and Factor-VIII-MVD, while the latter lost its prognostic impact when CD105/endoglin was included. In the subgroup with high MVD, there was a tendency towards improved response to radiation therapy. In conclusion, CD105/endoglin-MVD is significantly associated with FIGO stage, tumour proliferation and prognosis in endometrial carcinoma, indicating that this is a better angiogenic marker in these tumours.
4 Figures
    • Agrawal et al. reported that the ratio of p53/ Endoglin expression was associated with bladder recurrence in pTa and pT1 bladder cancer, but that Endoglin alone was not associated with bladder recurrence [20]. Also, in gastric and endometrial cancers, elevated level of Endoglin in blood serum, as well as in urine, can be seen [21,22]. Similar results have been reported in lung, prostatic, colorectal and breast cancers [23][24].
    [Show abstract] [Hide abstract] ABSTRACT: Objective: In this study, we aimed to compare plasma endoglin and endocan levels between bladder cancer patients and the control group. The secondary aim of the study was to compare plasma and tissue endoglin and endocan levels between high grade and low grade bladder cancers. Methods: A total of 36 patients with bladder cancer and 20 patients as control group were included. Eight milliliters of peripheral venous blood sample was taken from both study and control group to determine plasma Endocan and Endoglin levels. A tissue sample of 0.5 cm3 was obtained by cystoscopy and resection of papillary lesion of bladder to determine tissue Endocan and Endoglin levels. Results were compared between bladder cancer and control group. Result: The mean plasma Endoglin levels were 10.2 (4.5-13.7) ng/mL in low grade bladder cancer, 14.6 (8.4-22.3) ng/mL in high grade bladder cancer and 8.8 (6.3-19.4) ng/mL in the control group. The mean plasma Endocan levels were 520.4 (346.9-647.6) ng/L in low grade bladder tumors; 728.5 (311.4-1518.1) ng/L in high grade bladder tumors and 479.9 (140.6-864.7) ng/L in the control group. Plasma Endoglin level of control group was significantly lower than bladder cancer group (p
    Full-text · Article · Jun 2016
    • However such correlation has not been found in gallbladder[53]and hepatocellular carcinoma[54]. Through CD105, no significant association between MVD and p53 has been detected in ovarian[55]and endometrial cancer[56]. All these authors, except Takahashi et al., used p53 as a dichotomized variable[52].
    [Show abstract] [Hide abstract] ABSTRACT: Multistep carcinogenesis involves loss of function of tumor suppressor proteins such as p53 and induction of angiogenesis. Such mechanisms contribute to cutaneous squamous cell carcinoma progression and may be interconnected. We aimed to explore p53 immunoexpression in spectral stages of cutaneous squamous cell carcinoma and correlate expression to both neovascularization and cellular proliferation. We estimated the percentages of immunostained cells for p53 and Ki67 (proliferation marker) in three groups: 23 solar keratoses, 28 superficially invasive squamous cell carcinomas and 28 invasive squamous cell carcinomas. The Chalkley method was used to quantify the microvascular area by neoangiogenesis (CD105) immunomarker in each group. There was no significant difference for rate of p53- and Ki67-positive cells between groups. Significant positive correlation was found between the CD105 microvascular area and the rate of p53 positive cells in superficially invasive squamous cell carcinoma as well as between the rate of p53- and Ki67-positive cells in invasive squamous cell carcinoma. p53 and Ki67 immunoexpression did not increase with cutaneous squamous cell carcinoma progression. Neovascularization in the initial stage of invasion and proliferative activity in the frankly invasive stage were both associated with p53 immunoexpression. Loss of p53 tumor suppressor function through progressive steps may be directly involved in skin carcinogenesis.
    Full-text · Article · Jul 2015
    • A significant limitation is the variation in the methods for reporting the topography of the mast cells and macrophages (31). In addition, labeling the vessels for CD31 (24,25,27,28) or CD105 (33,34), the mast cells for tryptase (24,25,35), toluidine blue (27) or C-kit (26) and the macrophages for CD68 (29–31) or CD163 (28) may cause discrepancies.
    [Show abstract] [Hide abstract] ABSTRACT: The present study aimed to observe and compare the values of microvessel density (MVD), mast cell microdensity (McMD) and macrophage microdensity (MphMD) in intratumoral areas compared with the advancing edges, and to assess any correlations between these values and the degree and stage of the neoplasia. The cases of 52 patients who were diagnosed with endometrial carcinoma between 2003 and 2011 were analyzed, the majority of which were in the first stage of the disease (44 cases). Double sequential immunohistochemistry and the hot-spot counting method were used to assess the MVD (CD105(+) MVD), McMD [tryptase(+) (Try(+)) McMD] and MphMD (CD68(+) MphMD) densities. The χ(2) test, paired Student's t-test and the Pearson correlation index were used to assess the significance of the results. A weak correlation was observed at the advancing edge only, between CD105(+) MVD and Try(+) McMD (P=0.039). No significant differences were identified in the analysis of CD105(+) MVD, Try(+) McMD and CD68(+) MphMD, but wide variations in their distribution were observed. Depending on the tumor stage, CD105(+) MVD exhibited an intratumoral, indirect correlation with Try(+) McMD for stage IA (P=0.026) and II (P=0.013) tumors. CD105(+) MVD presented an indirect correlation with CD68(+) MphMD in stage IB tumors (P=0.016) and at the advancing edge for well-differentiated tumors (P=0.027). An analysis of the correlation between CD68(+) MphMD and Try(+) McMD indicated that the intratumoral levels of CD68(+) MphMD were directly proportional with the Try(+) McMD values in well-differentiated (P=0.005) and stage II (P=0.012) tumors, while at the front of the invasion, this correlation was indirect (P=0.010) in stage II tumors. In endometrioid endometrial carcinoma (EEC), angiogenesis is at its most active at the advancing edge of the tumor, where mast cells play a pro-angiogenic role.
    Full-text · Article · Aug 2013
    • These results were presented by Santos et al. [20] and Agrawal et al. [21]. Also, an elevated level of endoglin in blood serum, as well as in urine, can be typical of gastric (Salvensen et al. [22]) and endometrial cancers (Nikiteas et al. [23]). In our study, overexpression of BRIC5 was discovered in urine samples from patients with BC and compared to BRIC5 level in healthy people and revealed a statistically significant difference.
    [Show abstract] [Hide abstract] ABSTRACT: Bladder cancer (BC) is a serious medical problem. The high rate of recurrence and progression demands the development of new methods, such as genetic markers, which allow diagnosis and patient follow-up. The aim of this study was to compare expression of HIF-1, GLUT1, endoglin, and BRIC5 in patients without and those with BC. The second group was divided into sub-groups: those without a history of PDD (photodynamic diagnosis) in the diagnostic process and those after PDD. Patients with BC were diagnosed using the PDD method using hexaminolevulinate (Hexvix(®)). The expressions of HIF-1, GLUT1, endoglin, and BRIC5 genes were established in urine specimens by real-time quantitative polymerase chain reaction (PCR). The expressions of all tested genes were higher in the group of patients with BC than in the group without BC. In the group after PDD, a statistically significant overexpression of HIF-1 was observed. In this group, changes were not observed in cases of the other three tested genes. The differences between the group with PDD and the group without it can be connected with the direct influence of PDD on malignant tissue, which can cause overexpression of HIF-1 only. This is, however, only a hypothesis and needs further study.
    Full-text · Article · Sep 2012
    • Endoglin expression is a better prognostic marker than other traditional vessels markers, such as CD31 and CD34 [29, 32, 36, 38, 41]. In various tumours endoglin overexpression was associated with lower patient survival rates, presence of node metastases and distant metastatic disease2930313233343738394041. Endoglin has been examined as a target of antiangiogenic and antitumor therapy [25, 28].
    [Show abstract] [Hide abstract] ABSTRACT: Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes angiogenesis not only by activation of vascular endothelial cell proliferation but also by induction of the antiapoptotic pathway in hypoxic endothelial cells. The potential application of endoglin as a tumour angiogenesis marker, useful for cancer diagnostics and clinical application, is anticipated. Endoglin expression may be useful as an indicator of disease progression and helpful for estimation of recurrence and metastasis risk.
    Full-text · Article · Feb 2012
    • The transition from small dormant tumors to actively growing, invasive and metastatic tumors is shown to be associated with the so-called angiogenic switch, which implies that cancer cells gain the ability to induce formation of new blood vessels [7, 48]. Blood vessel density is further found to correlate with invasiveness and metastasis of many cancers49505152 . We therefore hypothesized that the differences in growth rate and invasiveness between the tongue and skin tumors in our experiments could be explained by a difference in vascularisation of the tumors in the two organs.
    [Show abstract] [Hide abstract] ABSTRACT: Squamous cell carcinomas (SCCs) arising in the oral cavity are associated with poor survival, mainly due to metastatic disease. In contrast, skin SCCs rarely metastasize and are usually curable. To study influence of tongue and skin stroma on cancer growth and induction of lymphangiogenesis, xenograft tumors of human carcinoma cells were established either in tongue or skin of BALB/c nude mice. Two oral and two skin SCC cell lines were used, as well as an endometrial adenocarcinoma cell line. Tongue tumors established from all cell lines were larger than corresponding skin tumors. Peritumoral lymphatic vessel density was up to five times higher in tongue than in corresponding skin tumors, and mRNA level of the lymphangiogenic growth factor vascular endothelial growth factor (VEGF)-C was twice as high in tongue tumors compared with corresponding skin tumors. Contrary to lymphatic vessel density, blood vessel density was higher in skin tumors than in tongue tumors. In a cohort of patient samples, lymphatic vessel density was found to be higher in tongue SCCs compared with skin SCCs, supporting a clinical relevance of our findings. Our results show that the tumor stroma has a profound impact on cancer growth and induction of lymphangiogenesis and angiogenesis. The difference in lymphatic vessel density between tongue and skin tumors may be important in directing metastatic potential of tumors arising in these organs.
    Full-text · Article · Oct 2010
Show more